W010

Klinische Studienzentrale
IDI:(DE-He78)W010-20160331

Recent Publications

All known publications ...
Download: BibTeX | EndNote XML,  Text | RIS | 

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;
Molecularly matched targeted therapies plus radiotherapy in glioblastoma: the phase 1/2a N2M2 umbrella trial.
Nature medicine nn, nn () [10.1038/s41591-025-03928-9]  GO BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article (Erratum/Correction)  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;
Author Correction: Risk of hematological malignancies from CT radiation exposure in children, adolescents and young adults.
Nature medicine 31(7), 2452 () [10.1038/s41591-025-03689-5]  GO BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;
Die Entwicklung eines neuen Impfstoffs gegen humane Papillomviren (HPV) im akademischen Umfeld – TEIL 2 / Papillomavirus Impfstoff PANHPVAX:First-in-Human – eine neue Herausforderung
PM/QM - Fachzeitschrift für pharmazeutische Medizin und Qualitätsmanagement - nur für Mitglieder 1, 46-54 ()  GO BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;
Venetoclax-based salvage therapy as bridge-to-transplant is feasible and effective in patients with relapsed/refractory AML.
Blood advances 9(2), 375-385 () [10.1182/bloodadvances.2024013086]  GO  Download fulltext Files BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;
Die Entwicklung eines neuen Impfstoffs gegen humane Papillomviren (HPV) im akademischen Umfeld – TEIL 1 Papillomavirus Impfstoff PANHPVAX: Herausfordernde Schritte von der Idee zur Erstanwendungsstudie
PM/QM - Fachzeitschrift für pharmazeutische Medizin und Qualitätsmanagement - nur für Mitglieder 26(3), 4-11 ()  GO BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article (Letter)  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;
Randomized phase III GnG study on two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and double-blinded intensive postremission therapy with or without glasdegib in patients with newly diagnosed acute myeloid leukemia.
Haematologica 109(6), 1973-1976 () [10.3324/haematol.2023.284346]  GO DBCoverage   Download fulltextFulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article (Letter)
Genetics as predictive marker for consolidation therapy with high-dose cytarabine in acute myeloid leukemia.
Haematologica 109(6), 1629 - 1630 () [10.3324/haematol.2024.285624]  GO DBCoverage BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;  ;  ;  ;  ;
Late-onset NPM1 mutation in a MYC-amplified relapsed / refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegib.
Haematologica 109(11), 3811-3815 () [10.3324/haematol.2023.284922]  GO DBCoverage BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;
Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease
Haematologica 109(5), 1385–1392 () [10.3324/haematol.2023.284310]  GO DBCoverage BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;
Treatment of chronic COVID-19 with convalescent/postvaccination plasma in patients with hematologic malignancies.
International journal of cancer 155(4), 618-626 () [10.1002/ijc.34988]  GO  Download fulltext Files BibTeX | EndNote: XML, Text | RIS

All known publications ...
Download: BibTeX | EndNote XML,  Text | RIS | 


 Record created 2019-10-24, last modified 2022-03-18



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)